We are in the midst of “the microbiome revolution”—not a day goes by without some new
revelation on the potential role of the gut microbiome in some disease or disorder. From an …

Background Nonalcoholic fatty liver disease (NAFLD) is the most prevalent chronic liver
disease worldwide. The pathogenesis of NAFLD is complex and multifactorial. There is …

Inborn errors of metabolism (IEMs) represent a complex system model, in need of a shift of
approach exploring the main factors mediating the regulation of the system, internal or …

Non-alcoholic fatty liver disease (NAFLD), which has a global prevalence of 20%–33%, has
become the main cause of chronic liver disease. Except for lifestyle medication, no definitive …

Chronic inflammation is a hallmark for a variety of disorders and is at least partially
responsible for disease progression and poor patient health. In recent years, the microbiota …

The articles referenced in this review help inform the reader on new decision-support
systems that can be based on multiomics patients' data including microbiome and immune …

The gut microbiota has a key role in the maintenance of good health, and in the
pathogenesis of gastrointestinal diseases. These conditions include the inflammatory bowel …

The modulation of gut microbiota dysbiosis might regulate the progression of metabolic-
associated fatty liver disease (MAFLD). Here, we found that polyphenol-rich Liupao tea …

Non-alcoholic fatty liver disease, commonly abbreviated to NAFLD, is a pervasive ailment
within the digestive system, exhibiting a rising prevalence, and impacting individuals at …

Non-alcoholic fatty liver disease (NAFLD) has become one of the most common chronic liver
diseases worldwide, causing serious economic and medical burdens. Currently, Chinese …